Corline Biomedical AB

Corline Biomedical ABverified

CLBIO.ST

Price:

$17.75

Market Cap:

$434.71M

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; CHC, which is used for the treatment of soft tissue injuries; medical devices; and CHS, a coronary stent. The company was founded in 1991 and is based in Uppsala, Sweden.

Industry

Biotechnology

IPO Date

2015-06-03

Stock Exchange

STO

Ticker

CLBIO.ST

The Enterprise Value as of December 2025 (TTM) for Corline Biomedical AB (CLBIO.ST) is 428.89M

According to Corline Biomedical AB’s latest financial reports and current stock price. The company's current Enterprise Value is 428.89M. This represents a change of 50.59% compared to the average of 284.81M of the last 4 quarters.

Corline Biomedical AB (CLBIO.ST) Historical Enterprise Value (quarterly & annually)

How has CLBIO.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Corline Biomedical AB over the last ten years is 198.07M. The current 428.89M Enterprise Value has changed 21.55% with respect to the historical average. Over the past ten years (40 quarters), CLBIO.ST's Enterprise Value was at its highest in in the September 2025 quarter at 479.10M. The Enterprise Value was at its lowest in in the June 2016 quarter at 62.51M.

Quarterly (TTM)
Annual

Average

198.07M

Median

201.01M

Minimum

95.23M

Maximum

303.20M

Corline Biomedical AB (CLBIO.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Corline Biomedical AB Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 76.82%

Maximum Annual Enterprise Value = 303.20M

Minimum Annual Increase = -42.67%

Minimum Annual Enterprise Value = 95.23M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024173.84M-42.67%
2023303.20M76.35%
2022171.94M-33.04%
2021256.79M6.86%
2020240.30M5.30%
2019228.19M-10.86%
2018256.01M76.82%
2017144.78M31.16%
2016110.39M15.91%
201595.23M26.21%

Corline Biomedical AB (CLBIO.ST) Average Enterprise Value

How has CLBIO.ST Enterprise Value performed in the past?

The current Enterprise Value of Corline Biomedical AB (CLBIO.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

216.32M

5-year avg

229.21M

10-year avg

198.07M

Corline Biomedical AB (CLBIO.ST) Enterprise Value vs. Peers

How is CLBIO.ST’s Enterprise Value compared to its peers?

Corline Biomedical AB’s Enterprise Value is less than Magle Chemoswed Holding AB (publ) (687.67M), greater than Mendus AB (publ) (224.40M), less than Enzymatica AB (publ) (440.34M), greater than Elicera Therapeutics AB (publ) (275.33M), greater than Ascelia Pharma AB (publ) (281.46M), greater than FluoGuide A/S (366.29M), greater than Xintela AB (publ) (175.97M), greater than Intervacc AB (publ) (134.45M), less than Bactiguard Holding AB (publ) (717.36M), greater than Bio-Works Technologies AB (publ) (164.97M),

Build a custom stock screener for Corline Biomedical AB (CLBIO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Corline Biomedical AB using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Corline Biomedical AB (CLBIO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Corline Biomedical AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Corline Biomedical AB's Enterprise Value?

What is the highest Enterprise Value for Corline Biomedical AB (CLBIO.ST)?

What is the 3-year average Enterprise Value for Corline Biomedical AB (CLBIO.ST)?

What is the 5-year average Enterprise Value for Corline Biomedical AB (CLBIO.ST)?

How does the current Enterprise Value for Corline Biomedical AB (CLBIO.ST) compare to its historical average?